Wellteq Digital Health Inc. announces shareholder approval of plan arrangement with Advanced Human Imaging

Wellteq Digital health Inc. announced today that holders of wellteq common shares have approved the plan of arrangement with Advanced Human Imaging Ltd (ASX, NASDAQ: AHI) (“AHI”).

November 24, 2022, Vancouver, British Columbia: wellteq Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF), (the “Company” or “wellteq”), announced today that holders of wellteq common shares (the “wellteq Shareholders”) have approved the plan of arrangement (the “Plan of Arrangement”) with Advanced Human Imaging Ltd (ASX, NASDAQ: AHI) (“AHI”), whereby AHI will acquire all of the outstanding shares of wellteq (the “Transaction”) as announced in its news release dated September 2, 2022.

At the special meeting of the wellteq Shareholders held on November 24, 2022 (the “Meeting”), the Plan of Arrangement was approved by 100% of the votes cast. Under the terms of the Plan of Arrangement, wellteq Shareholders will receive one AHI ordinary share (a “Consideration Share”) for every six wellteq common shares (a “wellteq Share”) held.
Registered wellteq Shareholders are reminded to complete, sign and return the letter of transmittal provided with the materials for the Meeting, together with the certificate(s) / DRS advice(s) representing their wellteq Shares as indicated in the letter of transmittal. Non-registered or beneficial wellteq Shareholders who hold their shares through a broker, investment dealer, nominee or other intermediary or depository (an “Intermediary”) should contact their Intermediary for instructions and assistance in depositing their wellteq Shares and receiving their Consideration Shares, and to confirm if their Intermediary has made arrangements for their Consideration Shares to be deposited into CHESS.
Closing of the Transaction is expected to occur in early December 2022, subject to obtaining a final order of the Supreme Court of British Columbia (the “Court”) and the satisfaction of other customary conditions. The hearing for approval of the final order by the Court is currently expected to take place on November 30, 2022. Following completion of the Transaction, wellteq intends to apply to have the wellteq Shares delisted from the Canadian Securities Exchange and to cease to be a reporting issuer. Additional information regarding the terms of the Transaction and the Plan of Arrangement are set forth in wellteq’s management information circular dated October 24, 2022, wellteq’s news release dated September 2, 2022 and the arrangement agreement between wellteq and AHI dated September 2, 2022, copies of which are available under wellteq’s profile at www.sedar.com.

About Advanced Human Imaging Ltd.

AHI, incorporated under the laws of the Commonwealth of Australia, has developed and patented a proprietary
dimensioning technology that enables users to check, track, and assess their dimensions and body composition
using only a smartphone privately and accurately. AHI has expanded its capabilities with the inclusion of
Transdermal Optical Imaging (TOI), allowing the capture of vital signs. The combination of the proprietary suite
delivers a unique risk assessment tool empowering users to check, track and action better health outcomes.
Whether a personal journey to better health, understanding the risk associated with physical condition, tracking the changes they are experiencing through training, dieting, or under medical regimes, through early risk identification. The AHI technology delivers this seamlessly, privately, and cost-effectively in only a few minutes.

AHI has developed this capability by leveraging the on device computational power of a smartphone to power its Computer Vision, Machine Learning, and patented algorithms, to process these images on secure, enterprise level infrastructure, delivering an end-to-end experience that is unrivalled in the industry. AHI simplifies the collection of these vital measurements and removes the human error present in traditional methods. To learn more, visit https://www.ahi.tech/.

About wellteq Digital Health Inc.

wellteq, incorporated under the laws of the Province of British Columbia, Canada, is a global digital health
provider, empowering people to be healthier and happier by coaching lasting behaviour change by delivering a
digital health platform to employers and insurance corporate customers, who in turn offer it to their employees
www.wellteq.co and policy holders, respectively. wellteq provides the supportive behavioural change that coaches people through lifestyle improvements. wellteq brings together a team of real people, connected by a shared purpose: to coach the world to better health. To learn more, visit http://www.wellteq.co.

To learn more, visit https://wellteq.co/

Download the wellteq Corporate Presentation:

wellteq Investor Contact:

Scott Montgomery, CEO of wellteq Digital Health Inc. at (604) 639-4529. 

Cautionary Note Regarding Forward-Looking Statements:

This news release contains information or statements that constitute “forward-looking statements.” Such forward looking statements
involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or
developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forwardlooking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified
by words such as “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “potential” and similar expressions, or
that events or conditions “will,” “would,” “may,” “could” or “should” occur.

Forward looking information may include, without limitation, statements regarding the operations, business, financial condition, expected
financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook of
Wellteq, and includes statements about, among other things, future developments and the future operations, strengths and strategies of
Wellteq. Forward-looking information is provided for the purpose of presenting information about management’s current expectations
and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. These
statements should not be read as guarantees of future performance or results.

The forward-looking statements made in this news release are based on management’s assumptions and analysis and other factors that
may be drawn upon by management to form conclusions and make forecasts or projections, including management’s experience and
assessments of historical trends, current conditions and expected future developments. Although management believes that these
assumptions, analyses and assessments are reasonable at the time the statements contained in this news release are made, actual results
may differ materially from those projected in any forward-looking statements. Examples of risks and factors that could cause actual
results to materially differ from forward-looking statements may include: the timing and unpredictability of regulatory actions; regulatory,
legislative, legal or other developments with respect to its operations or business; limited marketing and sales capabilities; early stage of
the industry and product development; limited products; reliance on third parties; unfavourable publicity or consumer perception; general
economic conditions and financial markets; the impact of increasing competition; the loss of key management personnel; capital
requirements and liquidity; access to capital; the timing and amount of capital expenditures; the impact of COVID-19; shifts in the demand
for Wellteq’s products and the size of the market; patent law reform; patent litigation and intellectual property; conflicts of interest; and
general market and economic conditions.

The forward-looking information contained in this news release represents the expectations of Wellteq as of the date of this news release
and, accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and
should not rely upon this information as of any other date. Wellteq undertakes no obligation to update these forward-looking statements
in the event that management’s beliefs, estimates or opinions, or other factors, should change.

The CSE has neither approved nor disapproved the contents of this news release.